Effect Of Rilapladib (SB-659032) On Platelet Aggregation

Clinical trial NCT00387257 · COMPLETED

Trial details

NCT number: NCT00387257
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Atherosclerosis

Start date: 2006-10-01
Primary completion: 2007-04-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.